Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionFusion protein combining an Fc antibody fragment with the extracellular region of a previously unknown membrane protein in the B7/CD28 family
Molecular Target T cell activation RhoGTPase activating protein (TAGAP)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today